US Patent Issued to Societe des Produits Nestle on Feb. 10 for "Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions" (Swiss, American Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,397, issued on Feb. 10, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions" was invented by Laura Trovo (Paudex, Switzerland), Bernard Cuenoud (Cully, Switzerland), Pascal Steiner (St. Louis) and Nicolas Preitner (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions containing at least one N-acetyl cysteine and at least one nicotinamide riboside for use in methods of prevention and/or treatment of neurological disease and/or ...